Spring Has Sprung!
Cindy & Hudson
|
HOT TOPIC: Breast Density
MAMMOGRAPHY:
MRI:
Irish study: How low can breast MR recalls go? Research conducted in Dublin finds the breast MRI recall rate is 10.8%, which compares well with other published data but is above U.K. national breast screening guidelines' minimum standard of less than 10% and an expected standard of less than 7%. Is that achievable? Maybe.
MRI pinpoints malignancy in extramammary disease. Assessing the entire field-of-view carefully for abnormalities on breast MRI studies is vital, because some incidental extramammary findings are malignant, and this alters diagnostic workup, staging, and treatment.
Study questions FDG-PET/CT for certain breast cancers. Researchers at Memorial Sloan Kettering Cancer Center found that only 3% of patients with newly diagnosed stage III invasive lobular breast cancer would have benefited from systemic staging with FDG-PET/CT, versus conventional CT and bone scanning.
MISCELLANEOUS ARTICLES:
Early Intervention Essential for Proper Lymphedema Management Moving early to diagnose and treat lymphedema after breast cancer treatment can reverse this side effect or prevent it from becoming more severe. Yet, a consistent way of defining lymphedema, measuring it, and identifying those most at risk remains elusive.
BEST BLOGS:
With Breast Density, a Gray Area for Screening Choices. Within the past half century, our profession has borne witness to an explosion of advancement, and with this has come a contemporaneous increase in both the need for sub-specialization and, bluntly, the associated cost of having more technology at our disposal.
QUOTE: RECIPE: Courtesy of Eating Well | |  |